For the record, I'm a long term *speculative* (because that's what everyone here is, bull and bear, in spite of their rhetoric) buyer but have never bought a share for the long term over a $150M market cap. And yes, I trade around that position as well as buying for ST trades based on the technicals since again, in spite what some bulls proclaim, there are NO fundamentals other than NAV for this stock, at least the way I define the term. Speculation on what may or may NOT happen in the future is not my definition of an investing "fundamental."
Not seeing the big ascending triangle balmoral, but totally agree w/ the sentiment. Multiple indicators *simultaneously* setting up bullish which hasn't happened in quite some time. Add in IBB's swift comeback from its June swoon and if that continues, all the elements are there. Keep in mind my view is from a short term trading perspective. Unlike most of the pie-in-the-sky bulls here, w/o FDA approval any meaningful rally to me will bring a valuation issue along with it.
It's called "resistance" if you believe in that thing called technical analysis. Non-believers can make up whatever they want as a reason. To believers, the current "setup" is as bullish as it has been in a long time to break through that area. Having said that, "breaking through" and "holding" are two very different things. We shall see.
They dumped most message boards years ago but kept Finance and a few others. Looks like they're indirectly going to make the remaining go away now.
Or how about ST traders, large and small who, btw, dominate market activity on a day to day basis in every issue. Selling begets selling among those guys who predominantly use "systems" and TA and are, for the most part, scalpers. I can't believe so many on these boards are so in the dark about this.
Try actually learning how the market maker system works before you go spouting any more of your ignorant "manipualtion" nonsense. IF demand at higher prices was present the share price would reflect it. SMH
Loving all the he-said-she-said this morning but in the long run it all means nothing at this time. Back to the only things that currently matter to share price, news, valuation, and the technicals, this morning's news happens to come right at key technical "hurdles" (sorry for the bad choice of words, no disrespect intended at all) and ergo the early struggle this morning. Hurdle #1, the 200 dma has been cleared but landing it safely is not yet a sure thing. Right behind is hurdle #2, strong resistance in the low 7s. Clearing and holding that area will, imho, spring the door wide open for a run to $10 and who knows depending on good ol' momentum or lack thereof. GLTA
The point was it's all about VALUE. Your "low" $400M market cap for an early stage development company is ridiculous by any valuation method. At least you used the operative word in this company's case "IF." And if that "if" turns into a "not" this is a penny stock in a heartbeat. I swear some of you guys need to watch Shark Tank every week to learn about how real money people think about valuations and investing.
400M LOW??? NO sales, NO earnings, NO APPROVED MARKETABLE PRODUCT. Allow me to introduce you to Benjamin Graham and Warren Buffett. Sheesh!
Short term bump, long term means absolutely nothing. Probably will be used to lighten up sans some material news to back it up.
Thanks smuf1! Any idea what exactly is/can be said to new patients and their decision makers especially in regards to info that would give the DMs the ability to search results for themselves?
patient 8's death might be having on new patients? I'm sure full disclosure must be made & just hearing that, regardless of no evidence the nss played a part, must give already frazzled minds even more trepidation. No new enrollments have occurred since. Just sayin'.
"This is a developmental phase biotech. Share price appreciation is typically based on sales, growth, etc. In development there are no sales, only speculation that FDA approval will happen at some point, and that is never a done deal, until the i's are dotted and the t's are crossed by the FDA."
And yet a few months ago you declared this a "risk free" investment. LOL. Another typical Yahoo mb poster, i.e., ZERO credibility.
"NVIV, on the other hand, is down because of the recent market fluctuations due to the vote in Britain."
That's almost as asinine as NVIV is a "risk free" investment. Maybe you've been asleep the past three days.